Combination treatment may slow disease progression in advanced sarcoma

An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet Oncology. “These findings support the combination as…

Continue Reading

News Source: medicalxpress.com